CVE-2020-8093
CVE-2020-8093 is a medium-severity vulnerability in Bitdefender Antivirus with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-74.
Key facts
- Severity: Medium (CVSS 3.x base score 5.3)
- CVSS v2: 4.6
- EPSS exploit prediction: 0% (37th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-74
- Affected product: Bitdefender Antivirus
- Published:
- Last modified:
Description
A vulnerability in the AntivirusforMac binary as used in Bitdefender Antivirus for Mac allows an attacker to inject a library using DYLD environment variable to cause third-party code execution
Frequently asked questions
- What is CVE-2020-8093?
- A vulnerability in the AntivirusforMac binary as used in Bitdefender Antivirus for Mac allows an attacker to inject a library using DYLD environment variable to cause third-party code execution
- How severe is CVE-2020-8093?
- CVE-2020-8093 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
- Is CVE-2020-8093 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (37th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2020-8093?
- CVE-2020-8093 affects Bitdefender Antivirus. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2020-8093?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2020-8093 published?
- CVE-2020-8093 was published on 2020-01-30 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:bitdefender:antivirus:*:*:*:*:*:*:*:*
More vulnerabilities in Bitdefender Antivirus
- CVE-2007-5775 — Critical (CVSS 9.8): Unspecified vulnerability in BitDefender allows attackers to execute arbitrary code via unspecified vectors, aka…
- CVE-2008-5409 — Critical (CVSS 9.3): Unspecified vulnerability in the pdf.xmd module in (1) BitDefender Free Edition 10 and Antivirus Standard 10, (2)…
- CVE-2025-7073 — High (CVSS 7.8): A local privilege escalation vulnerability in Bitdefender Total Security versions prior to 27.0.47.241 allows…
- CVE-2023-6154 — High (CVSS 7.8): A configuration setting issue in seccenter.exe as used in Bitdefender Total Security, Bitdefender Internet Security,…
- CVE-2019-17103 — Medium (CVSS 4.9): An Incorrect Default Permissions vulnerability in the BDLDaemon component of Bitdefender AV for Mac allows an attacker…
- CVE-2008-1735 — Medium (CVSS 4.9): BitDefender Antivirus 2008 20080118 and earlier allows local users to cause a denial of service (system crash) via an…
All CVEs affecting Bitdefender Antivirus →
Other CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities
- CVE-2026-122051 — Critical (CVSS 10.0): A flaw has been found in Edimax BR-6208AC 1.32. Affected by this vulnerability is an unknown functionality of the file…
- CVE-2026-120198 — Critical (CVSS 10.0): A vulnerability has been found in WAVLINK WL-WN530BE1-A V251117. Affected is the function con_check_read_finish of the…
- CVE-2026-114575 — Critical (CVSS 10.0): A flaw has been found in TOTOLINK A950RG 4.1.2cu.5268_B20221104. Affected by this issue is the function…
- CVE-2026-108918 — Critical (CVSS 10.0): A vulnerability was identified in Edimax BR-6208AC 1.32. Impacted is an unknown function of the file…
- CVE-2026-108917 — Critical (CVSS 10.0): A vulnerability was determined in Edimax BR-6208AC 1.32. This issue affects some unknown processing of the file…
- CVE-2026-105135 — Critical (CVSS 10.0): A vulnerability has been found in InternLM MindSearch 0.1.0. This issue affects the function ExecutionAction.run of the…
Browse all CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities →